Skip to main content

neonatal abstinence syndrome Archives

Patrick honored for neonatal abstinence syndrome research

Jun. 15, 2017—Stephen W. Patrick, M.D., MPH, MS, has been chosen to receive the Nemours Child Health Services Research Award, recognizing his work surrounding neonatal abstinence syndrome, a drug withdrawal syndrome experienced by infants exposed to opioids while in utero.

Read more

Reporter


Study finds male infants at increased risk for NAS

May. 4, 2017—Male infants are more likely at birth than their female counterparts to be diagnosed with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), and to require treatment, according to a new Vanderbilt study published in Hospital Pediatrics.

Read more

Health and Medicine Reporter Research


American Academy of Pediatrics, Vanderbilt neonatologist urge public health approach for women who use opioids during pregnancy

Feb. 20, 2017—Punitive approach has not been shown to be effective and may deter women from seeking help The American Academy of Pediatrics (AAP) issued a statement today stating that a public health response, rather than a punitive approach, is needed to address the increasing number of pregnant women using opioids. Vanderbilt neonatologist Stephen Patrick, M.D., co-authored...

Read more

Reporter


Standardizing care improves outcomes for infants born with neonatal abstinence syndrome

Apr. 15, 2016—Standardizing hospital care policies across institutions for infants diagnosed with drug withdrawal symptoms at birth reduces their length of treatment and hospitalization, according to new research led by Vermont Oxford Network, Vanderbilt and the University of Michigan Health System.

Read more

Health and Medicine Reporter Research


Infants born with NAS more likely to be readmitted: Study

Oct. 1, 2015—Infants diagnosed with drug withdrawal symptoms at birth, also known as neonatal abstinence syndrome (NAS), are nearly 2.5 times as likely to be readmitted to the hospital in the first month after being discharged compared with full-term infants born without complications, according to new Vanderbilt research released in the journal Hospital Pediatrics.

Read more

Healthcare Solutions Reporter


VUMC’s Patrick speaks to members of congress about neonatal abstinence syndrome

Jun. 29, 2015—Stephen Patrick, M.D., MPH, assistant professor of Pediatrics and Health Policy in the Division of Neonatology with the Monroe Carell Jr. Children’s Hospital at Vanderbilt, recently testified before congress about the rise in neonatal abstinence syndrome.

Read more

Reporter Research Research Blog


Babies born with drug withdrawal symptoms on rise

Apr. 30, 2015—The number of infants born in the United States with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), nearly doubled in a four-year period.

Read more

Health and Medicine Reporter Research


Vanderbilt study finds babies exposed to narcotic pain relievers more likely to experience drug withdrawal syndrome

Apr. 13, 2015—Legally prescribed narcotics taken during pregnancy can lead to neonatal abstinence syndrome, especially in combination with tobacco or SSRIs.

Read more

Health and Medicine Reporter Research


Care for newborns with drug withdrawal uneven: study

Jul. 17, 2014—In the United States, one infant is born each hour with drug withdrawal, known as neonatal abstinence syndrome (NAS), after being exposed to opioid medications like oxycodone in utero.

Read more

Health and Medicine Reporter Research